Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 18% ± 2% | |
glutamatergic neuron | 3 studies | 21% ± 1% | |
dendritic cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1264.56 | 459 / 459 | 100% | 24.69 | 1118 / 1118 |
esophagus | 100% | 1384.45 | 1445 / 1445 | 100% | 28.18 | 183 / 183 |
liver | 100% | 1754.45 | 226 / 226 | 100% | 16.07 | 406 / 406 |
ovary | 100% | 1039.93 | 180 / 180 | 100% | 13.34 | 430 / 430 |
uterus | 100% | 1111.41 | 170 / 170 | 100% | 17.88 | 459 / 459 |
prostate | 100% | 1024.90 | 245 / 245 | 100% | 15.80 | 501 / 502 |
bladder | 100% | 1288.38 | 21 / 21 | 100% | 14.45 | 502 / 504 |
thymus | 100% | 910.81 | 652 / 653 | 100% | 12.81 | 603 / 605 |
lung | 99% | 1030.80 | 575 / 578 | 100% | 20.75 | 1155 / 1155 |
intestine | 100% | 1207.94 | 966 / 966 | 99% | 13.75 | 523 / 527 |
kidney | 100% | 771.70 | 89 / 89 | 99% | 13.46 | 891 / 901 |
pancreas | 99% | 797.93 | 326 / 328 | 99% | 13.10 | 177 / 178 |
stomach | 100% | 1109.50 | 359 / 359 | 99% | 15.28 | 282 / 286 |
brain | 98% | 513.13 | 2599 / 2642 | 100% | 11.33 | 705 / 705 |
skin | 100% | 1559.65 | 1809 / 1809 | 96% | 15.34 | 451 / 472 |
adrenal gland | 100% | 659.74 | 258 / 258 | 90% | 6.75 | 208 / 230 |
adipose | 100% | 1415.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1354.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.82 | 29 / 29 |
muscle | 100% | 1339.38 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1167.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.54 | 1 / 1 |
heart | 99% | 832.77 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 882.45 | 782 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 5.23 | 58 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0062026 | Biological process | negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990444 | Molecular function | F-box domain binding |
GO_0001691 | Molecular function | pseudophosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | STYX |
Protein name | Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase STYX) (Phosphoserine/threonine/tyrosine interaction protein) |
Synonyms | |
Description | FUNCTION: Catalytically inactive phosphatase . Acts as a nuclear anchor for MAPK1/MAPK3 (ERK1/ERK2) . Modulates cell-fate decisions and cell migration by spatiotemporal regulation of MAPK1/MAPK3 (ERK1/ERK2) . By binding to the F-box of FBXW7, prevents the assembly of FBXW7 into the SCF E3 ubiquitin-protein ligase complex, and thereby inhibits degradation of its substrates . Plays a role in spermatogenesis (By similarity). . |
Accessions | ENST00000354586.5 ENST00000442123.6 Q8WUJ0 |